Long Shot : Vaccines for National Defense / Kendall Hoyt.
2012
Linked e-resources
Linked Resource
Online Access
Details
Title
Long Shot : Vaccines for National Defense / Kendall Hoyt.
Author
Hoyt, Kendall, author.
ISBN
9780674063150
Published
Cambridge, MA : Harvard University Press, [2012]
Copyright
©2011
Language
English
Language Note
In English.
Description
1 online resource (314 p.) : 1 halftone, 6 line illustrations, 8 tables
Other Standard Identifiers
10.4159/harvard.9780674063150 doi
Dewey Decimal Classification
614.4/7
Summary
At the turn of the twenty-first century, the United States contended with a state-run biological warfare program, bioterrorism, and a pandemic. Together, these threats spurred large-scale government demand for new vaccines, but few have materialized. A new anthrax vaccine has been a priority since the first Gulf War, but twenty years and a billion dollars later, the United States still does not have one. This failure is startling.Historically, the United States has excelled at responding to national health emergencies. World War II era programs developed ten new or improved vaccines, often in time to meet the objectives of particular military missions. Probing the history of vaccine development for factors that foster timely innovation, Kendall Hoyt discovered that vaccine innovation has been falling, not rising, since World War II. This finding is at odds with prevailing theories of market-based innovation and suggests that a collection of nonmarket factors drove mid-century innovation. Ironically, many late-twentieth-century developments that have been celebrated as a boon for innovation-the birth of a biotechnology industry and the rise of specialization and outsourcing-undercut the collaborative networks and research practices that drove successful vaccine projects in the past.Hoyt's timely investigation teaches important lessons for our efforts to rebuild twenty-first-century biodefense capabilities, especially when the financial payback for a particular vaccine is low, but the social returns are high.
Access Note
Access limited to authorized users.
System Details Note
Mode of access: Internet via World Wide Web.
Digital File Characteristics
text file PDF
Source of Description
Description based on online resource; title from PDF title page (publisher's Web site, viewed 30. Aug 2021)
In
E-BOOK GESAMTPAKET / COMPLETE PACKAGE 2012
E-BOOK PACKAGE MEDICINE 2012
E-BOOK PAKET MEDIZIN 2012
HUP eBook-Package Backlist 2000-2013 (Canada)
Harvard University Press eBook Package Backlist 2000-2013
E-BOOK PACKAGE MEDICINE 2012
E-BOOK PAKET MEDIZIN 2012
HUP eBook-Package Backlist 2000-2013 (Canada)
Harvard University Press eBook Package Backlist 2000-2013
Linked Resources
Online Access
Record Appears in
Online Resources > Ebooks
All Resources
All Resources
Table of Contents
Frontmatter
Contents
Text Acronyms
Introduction
1. Disease, Security, and Vaccines
2. Historical Patterns of Vaccine Innovation
3. Vaccine Development during World War II
4. Wartime Legacies
5. The End of an Era
6. Biodefense in the Twenty-First Century
7. The Search for Sustainable Solutions
Appendices
Notes
Acknowledgments
Index
Contents
Text Acronyms
Introduction
1. Disease, Security, and Vaccines
2. Historical Patterns of Vaccine Innovation
3. Vaccine Development during World War II
4. Wartime Legacies
5. The End of an Era
6. Biodefense in the Twenty-First Century
7. The Search for Sustainable Solutions
Appendices
Notes
Acknowledgments
Index